Depletion of hepatic Kiss1r exacerbated hepatic steatosis, while the pharmacological enhancement of KISS1R signaling lowered hepatic triglyceride content, serum triglyceride levels, and serum free fatty acid levels [8]. This evidence concerns the gene KISS1R and Hepatic steatosis.